Stephen Hill has joined Lyell Immunopharma as the new Chief Technology Officer. Hill has joined from AstraZeneca, where he served as Vice President of Manufacturing Operations before he was promoted to Senior Vice President of Global Head of Biologics Operations. Prior to AstraZeneca, Hill enjoyed increasing levels of responsibilities at Amgen. Hill has obtained his MBA from the University of Washington in 2002.
This search was successfully led by Michael Cane.
At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Our firm has offices in Los Angeles, Silicon Valley, and Seattle, serving clients on a local, national and global basis.
Westwood & Wilshire, LLC
Offices in Los Angeles, Silicon Valley, Seattle, and Scottsdale
© Westwood & Wilshire LLC. All Rights Reserved.